H.R. 2541 (119th)Bill Overview

Nuclear Medicine Clarification Act of 2025

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Apr 1, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill directs the Nuclear Regulatory Commission (NRC) to revise 10 C.F.R. §35.3045(a)(1) to add explicit reporting thresholds for unintended irradiation from extravasation during nuclear medicine procedures. It defines two numeric dose thresholds (0.5 Sv to 5 cc tissue or 0.5 Sv shallow dose to 10 cm² skin) as reportable medical events.

Why people may split

Progressives stress stronger patient protections and lower thresholds

Watch point

Relative to its intended legislative type, this bill is a focused substantive change that clearly specifies the regulatory language to be added and sets firm timelines.

The bill directs the Nuclear Regulatory Commission (NRC) to revise 10 C.F.R. §35.3045(a)(1) to add explicit reporting thresholds for unintended irradiation from extravasation during nuclear medicine procedures.

It defines two numeric dose thresholds (0.5 Sv to 5 cc tissue or 0.5 Sv shallow dose to 10 cm² skin) as reportable medical events.

The NRC must issue the revised regulation within 120 days of enactment, and the change becomes effective 18 months after enactment.

Passage65/100

Technically focused patient-safety bill with low controversy and limited fiscal impact, so reasonably likely to advance.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a focused substantive change that clearly specifies the regulatory language to be added and sets firm timelines. It provides strong mechanism specificity and identifies the responsible agency and effective date, but omits fiscal acknowledgement, technical definitions, measurement methodology, and accountability provisions.

Contention50/100

Progressives stress stronger patient protections and lower thresholds

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitCreates specific reporting thresholds that can improve detection of harmful extravasation events.
  • Potential benefitMay increase patient safety by prompting investigation and mitigation after higher-dose extravasations.
  • Potential benefitProvides clearer regulatory guidance for providers on when to report medical events.
Likely burdened
  • Potential burdenImposes additional administrative reporting obligations on nuclear medicine facilities and staff.
  • Potential burdenMay raise compliance costs for facilities needing measurement protocols and recordkeeping updates.
  • Potential burdenCould increase legal and liability exposure for providers by codifying specific numerical thresholds.
03 · Why people split

Why the argument around this bill splits.

Progressives stress stronger patient protections and lower thresholds
Progressive85%

Likely supportive because the bill clarifies patient-safety reporting and closes a regulatory gap around extravasation injuries.

They will want stronger patient protections, lower thresholds, and mandatory patient notification or remediation steps added.

Some effects (like whether thresholds are sufficiently protective) are uncertain and depend on the NRC's implementing rule.

Leans supportive
Centrist70%

Generally favorable to clearer, narrowly focused regulation that standardizes reporting and improves safety while leaving technical rulemaking to the NRC.

Will emphasize careful implementation, stakeholder input, and cost-benefit documentation.

Support is conditional on reasonable implementation timelines and guidance to reduce compliance burdens.

Leans supportive
Conservative35%

Cautiously skeptical: supports patient safety objectives but concerned about federal prescriptiveness, rushed deadlines, and compliance costs.

Prefers evidence-based thresholds set through deliberative NRC processes and minimal new regulatory burden on providers.

May oppose if rulemaking appears arbitrary or costly.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood65/100

Technically focused patient-safety bill with low controversy and limited fiscal impact, so reasonably likely to advance.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No cost estimate or agency implementation analysis included
  • Interaction and coordination with Agreement States' regulations
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives stress stronger patient protections and lower thresholds

Technically focused patient-safety bill with low controversy and limited fiscal impact, so reasonably likely to advance.

Unlocked analysis

Relative to its intended legislative type, this bill is a focused substantive change that clearly specifies the regulatory language to be added and sets firm timelines. It provides strong mechanism specificity and ident…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis